Skip to main content
P.H. flag

Unofficial COVID-19 PH Tracker

Icon by icons8.com

disease.sh - Open Disease Data
Sourced data from Johns Hopkins University, the New York Times, Worldometers, and Apple reports to give you a comprehensive view of the data.

Image of Vicente G. Reyes

Developed by Vicente G. Reyes
A Self-Directed Learner, a Freelance Web Developer, a Volunteer Developer at Project Website, Moderator at DEV, & a Podcast host. www.vgreyes.com

  • Candidate: BNT162

    Mechanism: mRNA-based vaccine

    Spnosor: Pfizer, BioNTech

    Trial Phase: Phase 3

    Institution: Multiple study sites in Europe, North America and China

  • Candidate: mRNA-1273

    Mechanism: mRNA-based vaccine

    Spnosor: Moderna

    Trial Phase: Phase 3

    Institution: Kaiser Permanente Washington Health Research Institute

  • Candidate: Ad5-nCoV

    Mechanism: Recombinant vaccine (adenovirus type 5 vector)

    Spnosor: CanSino Biologics

    Trial Phase: Phase 3

    Institution: Tongji Hospital, Wuhan, China

  • Candidate: AZD1222

    Mechanism: Replication-deficient viral vector vaccine (adenovirus from chimpanzees)

    Spnosor: The University of Oxford, AstraZeneca, IQVIA, Serum Institute of India

    Trial Phase: Phase 3

    Institution: The University of Oxford, , the Jenner Institute

  • Candidate: CoronaVac

    Mechanism: Inactivated vaccine (formalin with alum adjuvant)

    Spnosor: Sinovac

    Trial Phase: Phase 3

    Institution: Sinovac Research and Development Co., Ltd.

  • Candidate: Covaxin

    Mechanism: Inactivated vaccine

    Spnosor: Bharat Biotech, National Institute of Virology

    Trial Phase: Phase 3

    Institution:

  • Candidate: JNJ-78436735 (formerly Ad26.COV2.S)

    Mechanism: Non-replicating viral vector

    Spnosor: Johnson & Johnson

    Trial Phase: Phase 3

    Institution: Johnson & Johnson

  • Candidate: No name announced

    Mechanism: Inactivated vaccine

    Spnosor: Wuhan Institute of Biological Products, China National Pharmaceutical Group (Sinopharm)

    Trial Phase: Phase 3

    Institution: Henan Provincial Center for Disease Control and Prevention

  • Candidate: NVX-CoV2373

    Mechanism: Nanoparticle vaccine

    Spnosor: Novavax

    Trial Phase: Phase 3

    Institution: Novavax

  • Candidate: Sputnik V

    Mechanism: Non-replicating viral vector

    Spnosor: Gamaleya Research Institute, Acellena Contract Drug Research and Development

    Trial Phase: Phase 3

    Institution: Various

  • Candidate: Bacillus Calmette-Guerin (BCG) vaccine

    Mechanism: Live-attenuated vaccine

    Spnosor: University of Melbourne and Murdoch Children&rsquo, s Research Institute, Radboud University Medical Center, Faustman Lab at Massachusetts General Hospital

    Trial Phase: Phase 2/3

    Institution: University of Melbourne and Murdoch Children&rsquo, s Research Institute, Radboud University Medical Center, Faustman Lab at Massachusetts General Hospital

  • Candidate: INO-4800

    Mechanism: DNA vaccine (plasmid)

    Spnosor: Inovio Pharmaceuticals

    Trial Phase: Phase 2/3

    Institution: Center for Pharmaceutical Research, Kansas City. Mo., University of Pennsylvania, Philadelphia

  • Candidate: VIR-7831

    Mechanism: Plant-based adjuvant vaccine

    Spnosor: Medicago, GSK, Dynavax

    Trial Phase: Phase 2/3

    Institution: Medicago

  • Candidate: No name announced

    Mechanism: Recombinant vaccine

    Spnosor: Anhui Zhifei Longcom Biopharmaceutical, Institute of Microbiology of the Chinese Academy of Sciences

    Trial Phase: Phase 2

    Institution: Various

  • Candidate: ZyCoV-D

    Mechanism: DNA vaccine (plasmid)

    Spnosor: Zydus Cadila

    Trial Phase: Phase 2

    Institution: Zydus Cadila

  • Candidate: No name announced

    Mechanism: Adjuvanted protein subunit vaccine

    Spnosor:

    Trial Phase: Phase 1/2

    Institution:

  • Candidate: AG0301-COVID19

    Mechanism: DNA vaccine

    Spnosor: AnGes, Inc.

    Trial Phase: Phase 1/2

    Institution: AnGes, Inc., Japan Agency for Medical Research and Development

  • Candidate: BBIBP-CorV

    Mechanism: Inactivated vaccine

    Spnosor: Beijing Institute of Biological Products, China National Pharmaceutical Group (Sinopharm)

    Trial Phase: Phase 1/2

    Institution: Henan Provincial Center for Disease Control and Prevention

  • Candidate: EpiVacCorona

    Mechanism: Peptide vaccine

    Spnosor: Federal Budgetary Research Institution State Research Center of Virology and Biotechnology

    Trial Phase: Phase 1/2

    Institution: Federal Budgetary Research Institution State Research Center of Virology and Biotechnology

  • Candidate: GX-19

    Mechanism: DNA vaccine

    Spnosor: Genexine

    Trial Phase: Phase 1/2

    Institution:

  • Candidate: LNP-nCoVsaRNA

    Mechanism: Self-amplifying RNA vaccine

    Spnosor: Imperial College London

    Trial Phase: Phase 1/2

    Institution: Imperial College London

  • Candidate: ARCT-021 (LUNAR-COV19)

    Mechanism: Self-replicating RNA vaccine

    Spnosor: Arcturus Therapeutics , and , Duke-NUS Medical School

    Trial Phase: Phase 1/2

    Institution: Duke-NUS Medical School, Singapore

  • Candidate: No name announced

    Mechanism: Protein subunit vaccine

    Spnosor: Sanofi, GlaxoSmithKline

    Trial Phase: Phase 1/2

    Institution: Various

  • Candidate: No name announced

    Mechanism: Inactivated vaccine

    Spnosor: Chinese Academy of Medical Sciences, Institute of Medical Biology

    Trial Phase: Phase 1/2

    Institution: West China Second University Hospital, Yunnan Center for Disease Control and Prevention

  • Candidate: AdimrSC-2f

    Mechanism: Protein subunit vaccine

    Spnosor: Adimmune

    Trial Phase: Phase 1

    Institution: Adimmune

  • Candidate: bacTRL-Spike

    Mechanism: Monovalent oral vaccine (bifidobacteria)

    Spnosor: Symvivo

    Trial Phase: Phase 1

    Institution: Symvivo Corporation

  • Candidate: COVAX-19

    Mechanism: Monovalent recombinant protein vaccine

    Spnosor: Vaxine Pty Ltd.

    Trial Phase: Phase 1

    Institution: Royal Adelaide Hospital

  • Candidate: CVnCoV

    Mechanism: mRNA-based vaccine

    Spnosor: CureVac

    Trial Phase: Phase 1

    Institution: CureVac

  • Candidate: DelNS1-2019-nCoV-RBD-OPT1

    Mechanism: Replicating viral vector

    Spnosor: Xiamen University, Beijing Wantai Biological Pharmacy

    Trial Phase: Phase 1

    Institution: Jiangsu Provincial Centre For Disease Control and Prevention

  • Candidate: GRAd-COV2

    Mechanism: Adenovirus-based vaccine

    Spnosor: ReiThera, Leukocare, Univercells

    Trial Phase: Phase 1

    Institution: Lazzaro Spallanzani National Institute for Infectious Diseases

  • Candidate: UQ-CSL V451

    Mechanism: Protein subunit vaccine

    Spnosor: CSL, The University of Queensland

    Trial Phase: Phase 1

    Institution:

  • Candidate: No name announced

    Mechanism: Adenovirus-based vaccine

    Spnosor: ImmunityBio, NantKwest

    Trial Phase: Phase 1

    Institution:

  • Candidate: SCB-2019

    Mechanism: Protein subunit vaccine

    Spnosor: GlaxoSmithKline, , Sanofi, , Clover Biopharmaceuticals, Dynavax , and Xiamen Innovax, CEPI

    Trial Phase: Phase 1

    Institution: Linear Clinical Research (Australia)

  • Candidate: UB-612

    Mechanism: Multitope peptide-based vaccine

    Spnosor: COVAXX

    Trial Phase: Phase 1

    Institution: United Biomedical Inc. (UBI)

  • Candidate: V590

    Mechanism: Recombinant vaccine (vesicular stomatitis virus)

    Spnosor: Merck, IAVI

    Trial Phase: Phase 1

    Institution:

  • Candidate: V591

    Mechanism: Measles vector vaccine

    Spnosor: University of Pittsburgh’s Center for Vaccine Research

    Trial Phase: Phase 1

    Institution: University of Pittsburgh, Themis Biosciences, Institut Pasteur

  • Candidate: VXA-CoV2-1

    Mechanism: Recombinant vaccine (adenovirus type 5 vector)

    Spnosor: Vaxart

    Trial Phase: Phase 1

    Institution: Vaxart

  • Candidate: AAVCOVID

    Mechanism: Gene-based vaccine

    Spnosor: Massachusetts Eye and Ear, Massachusetts General Hospital, University of Pennsylvania

    Trial Phase: Pre-clinical

    Institution:

  • Candidate: AdCOVID

    Mechanism: Intranasal vaccine

    Spnosor: Altimmune

    Trial Phase: Pre-clinical

    Institution: University of Alabama at Birmingham

  • Candidate: ChAd-SARS-CoV-2-S

    Mechanism: Adenovirus-based vaccine

    Spnosor: Washington University School of Medicine in St. Louis

    Trial Phase: Pre-clinical

    Institution: Washington University School of Medicine in St. Louis

  • Candidate: HaloVax

    Mechanism: Self-assembling vaccine

    Spnosor: Voltron Therapeutics, Inc., Hoth Therapeutics, Inc.

    Trial Phase: Pre-clinical

    Institution: MGH Vaccine and Immunotherapy Center

  • Candidate: HDT-301

    Mechanism: RNA vaccine

    Spnosor: University of Washington, National Institutes of Health Rocky Mountain Laboratories, HDT Bio Corp

    Trial Phase: Pre-clinical

    Institution:

  • Candidate: LineaDNA

    Mechanism: DNA vaccine

    Spnosor: Takis Biotech

    Trial Phase: Pre-clinical

    Institution: Takis Biotech

  • Candidate: MRT5500

    Mechanism: Recombinant vaccine

    Spnosor: Sanofi, Translate Bio

    Trial Phase: Pre-clinical

    Institution:

  • Candidate: No name announced

    Mechanism: Ii-Key peptide COVID-19 vaccine

    Spnosor: Generex Biotechnology

    Trial Phase: Pre-clinical

    Institution: Generex

  • Candidate: No name announced

    Mechanism: Protein subunit vaccine

    Spnosor: University of Saskatchewan Vaccine and Infectious Disease Organization-International Vaccine Centre

    Trial Phase: Pre-clinical

    Institution: University of Saskatchewan Vaccine and Infectious Disease Organization-International Vaccine Centre

  • Candidate: No name announced

    Mechanism: mRNA-based vaccine

    Spnosor: Chulalongkorn University’s Center of Excellence in Vaccine Research and Development

    Trial Phase: Pre-clinical

    Institution:

  • Candidate: No name announced

    Mechanism: gp96-based vaccine

    Spnosor: Heat Biologics

    Trial Phase: Pre-clinical

    Institution: University of Miami Miller School of Medicine

  • Candidate: No name announced

    Mechanism: Inactivated vaccine

    Spnosor: Shenzhen Kangtai Biological Products

    Trial Phase: Pre-clinical

    Institution:

  • Candidate: PittCoVacc

    Mechanism: Recombinant protein subunit vaccine (delivered through microneedle array)

    Spnosor: UPMC/University of Pittsburgh School of Medicine

    Trial Phase: Pre-clinical

    Institution: University of Pittsburgh

  • Candidate: T-COVIDTM

    Mechanism: Intranasal vaccine

    Spnosor: Altimmune

    Trial Phase: Pre-clinical

    Institution: